The Nigerian Content Development and Monitoring Board (NCDMB) and Nigeria Liquefied Natural Gas (NLNG) Limited have ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...